WallStreetZenWallStreetZen

NASDAQ: EVGN
Evogene Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their EVGN stock forecasts and price targets.

Forecast return on equity

Is EVGN forecast to generate an efficient return?
Company
-138.5%
Industry
27.82%
Market
24.1%
EVGN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EVGN forecast to generate an efficient return on assets?
Company
-32.67%
Industry
10.41%
EVGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EVGN revenue forecast

What is EVGN's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$34.9M+519.33%
EVGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EVGN revenue growth forecast

How is EVGN forecast to perform vs Biotechnology companies and vs the US market?
Company
519.33%
Industry
318.21%
Market
14.1%
EVGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EVGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EVGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EVGN$0.66N/AN/A
SABS$3.63$15.50+327.00%Strong Buy
PLUR$6.10N/AN/A
RNXT$1.37$4.00+191.97%Strong Buy
LPCN$6.04N/AN/A
View Top Biotech Stocks

Evogene Stock Forecast FAQ

What is EVGN's revenue growth forecast for 2024-2024?

(NASDAQ: EVGN) Evogene's forecast annual revenue growth rate of 519.33% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 318.21%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.1%.

Evogene's revenue in 2024 is $5,640,000.

In 2024, EVGN is forecast to generate $1,766,919,659 in revenue, with the lowest revenue forecast at $1,766,919,659 and the highest revenue forecast at $1,766,919,659.

If you're new to stock investing, here's how to buy Evogene stock.

What is EVGN's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: EVGN) forecast ROA is -32.67%, which is lower than the forecast US Biotechnology industry average of 10.41%.

What is EVGN's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: EVGN) forecast ROE is -138.5%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.